Comparison of Three Jet Nebulizer Aerosol Delivery Systems Used to Administer Recombinant Human DNase I to Patients With Cystic Fibrosis

This publication has 10 references indexed in Scilit:

• Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
  New England Journal of Medicine, 1994
• Characterization of Aerosols of Human Recombinant Deoxyribonuclease I (rhDNase) Generated by Jet Nebulizers
  Pharmaceutical Research, 1994
• Efficacy and Safety of Short-term Administration of Aerosolized Recombinant Human Deoxyribonuclease in Patients with Cystic Fibrosis
  American Review of Respiratory Disease, 1993
• Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis
  The Lancet, 1993
• Lung Function Testing: Selection of Reference Values and Interpretative Strategies
  American Review of Respiratory Disease, 1991
• Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
  Proceedings of the National Academy of Sciences, 1990
• Droplets Produced by Medical Nebulizers
  Chest, 1990
• Standardization of Spirometry—1987 Update
  American Review of Respiratory Disease, 1987
• Pus, deoxyribonucleic acid, and sputum viscosity.
  Thorax, 1978
• COMPOSITION OF TRACHEOBRONCHIAL SECRETIONS IN CYSTIC FIBROSIS OF THE PANCREAS AND BRONCHIECTASIS
  Pediatrics, 1959